Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 11.80 ($0.15) and last traded at GBX 12.31 ($0.16), with a volume of 1368061 shares traded. The stock had previously closed at GBX 12.88 ($0.17).
Creo Medical Group Trading Up 6.1 %
The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The stock has a market capitalization of £52.55 million, a PE ratio of -2.06 and a beta of 0.86. The business’s 50-day moving average is GBX 15.85 and its two-hundred day moving average is GBX 18.75.
Insider Transactions at Creo Medical Group
In other Creo Medical Group news, insider Richard John Rees purchased 4,712 shares of Creo Medical Group stock in a transaction that occurred on Thursday, January 16th. The stock was purchased at an average price of GBX 19 ($0.25) per share, for a total transaction of £895.28 ($1,158.79). Insiders own 22.43% of the company’s stock.
About Creo Medical Group
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.
Read More
- Five stocks we like better than Creo Medical Group
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- What Investors Need to Know About Upcoming IPOs
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
